| PERIOD ENDING | 28-Feb-09 | 29-Feb-08 | 28-Feb-07 | | Total Revenue | 40,210 | 25,472 | 57,082 | | Cost of Revenue | 2,045 | 3,180 | 3,159 | | | Gross Profit | 38,165 | 22,292 | 53,923 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 205 | 190 | 193 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 37,960 | 22,102 | 53,730 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (120,504) | (31,766) | (4,615) | | Earnings Before Interest And Taxes | 37,960 | 4,825 | 3,079 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 37,960 | 4,825 | 3,079 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (82,544) | (9,664) | 49,115 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (82,544) | (9,664) | 49,115 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($82,544) | ($9,664) | $49,115 |
|
0.03% Nasdaq 
0.29 (1.81%) 
Income Statement
